Abnormal changes in the quantity and function of osteoblasts cultured in vitro in patients with myelodysplastic syndrome

Gao,Shan; Wang,Huaquan; Jiang,Huijuan; Fu,Rong; Yu,Hong; Liu,Chunyan; Tao,Jinglian; Shao,Zonghong

doi:10.3892/ol.2018.9206

Abnormal changes in the quantity and function of osteoblasts cultured in vitro in patients with myelodysplastic syndrome

Authors:
- Shan Gao
- Huaquan Wang
- Huijuan Jiang
- Rong Fu
- Hong Yu
- Chunyan Liu
- Jinglian Tao
- Zonghong Shao
View Affiliations

Affiliations: Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China
Published online on: July 24, 2018 https://doi.org/10.3892/ol.2018.9206
Pages: 4384-4390
Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Changes in bone marrow niches can lead to the occurrence of myelodysplastic syndrome (MDS). As an important part of the bone marrow niche, osteoblasts serve a key role in the progression of MDS. The present study investigated the quantity and function of osteoblasts and, through in vitro assays, detected changes in signaling pathways and the association with progression in MDS patients. The ratios of osteoprogenitors (CD34+OCN+) and OCN+CD34‑Lin‑ osteoblasts in MDS patients were significantly less than those of normal controls. The results of this study demonstrated that the quantity and activity of osteoblasts in MDS patients were lower than those in normal controls. Furthermore the activity of osteoblasts in patients correlated with the severity of MDS. The quantity of osteoblasts cultured in vitro from high‑risk and very high‑risk MDS patients (WHO Classification‑Based Prognostic Scoring System score 3‑6) was decreased. The levels of T‑cell immunoglobulin and mucin domain‑containing 3 (TIM3) and Jagged 1 were also increased in the osteoblasts in vitro. These results indicated that osteoblasts are abnormally altered in MDS patients, and that there are associations between abnormal changes of osteoblasts and the severity of MDS.

View Figures

View References

1	Bulycheva E, Rauner M, Medyouf H, Theurl I, Bornhäuser M, Hofbauer LC and Platzbecker U: Myelodysplasia is in the niche: Novel concepts and emerging therapies. Leukemia. 29:259–268. 2015. View Article : Google Scholar : PubMed/NCBI
2	Méndez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN and Frenette PS: Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 466:829–834. 2010. View Article : Google Scholar : PubMed/NCBI
3	Arai F and Suda T: Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Ann N Y Acad Sci. 1106:41–53. 2007. View Article : Google Scholar : PubMed/NCBI
4	Bowers M, Zhang B, Ho Y, Agarwal P, Chen CC and Bhatia R: Osteoblast ablation reduces normal long-term hematopoietic stem cell self-renewal but accelerates leukemia development. Blood. 125:2678–2688. 2015. View Article : Google Scholar : PubMed/NCBI
5	Raaijmakers MH, Mukherjee S, Guo S, Zhang S, Kobayashi T, Schoonmaker JA, Ebert BL, Al-Shahrour F, Hasserjian RP, Scadden EO, et al: Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature. 464:852–857. 2010. View Article : Google Scholar : PubMed/NCBI
6	Brennan-Speranza TC and Conigrave AD: Osteocalcin: An osteoblast-derived polypeptide hormone that modulates whole body energy metabolism. Calcif Tissue Int. 96:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
7	Youngstrom DW, Dishowitz MI, Bales CB, Carr E, Mutyaba PL, Kozloff KM, Shitaye H, Hankenson KD and Loomes KM: Jagged1 expression by osteoblast-lineage cells regulates trabecular bone mass and periosteal expansion in mice. Bone. 91:64–74. 2016. View Article : Google Scholar : PubMed/NCBI
8	Sakuishi K, Jayaraman P, Behar SM, Anderson AC and Kuchroo VK: Emerging Tim-3 functions in antimicrobial and tumor immunity. Trends Immunol. 32:345–349. 2011. View Article : Google Scholar : PubMed/NCBI
9	Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellström-Lindberg E, Tefferi A and Bloomfield CD: The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood. 114:937–951. 2009. View Article : Google Scholar : PubMed/NCBI
10	Malcovati L, Della Porta MG, Strupp C, Ambaglio I, Kuendgen A, Nachtkamp K, Travaglino E, Invernizzi R, Pascutto C, Lazzarino M, et al: Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS). Haematologica. 96:1433–1440. 2011. View Article : Google Scholar : PubMed/NCBI
11	Schepers K, Pietras EM, Reynaud D, Flach J, Binnewies M, Garg T, Wagers AJ, Hsiao EC and Passegué E: Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell. 13:285–299. 2013. View Article : Google Scholar : PubMed/NCBI
12	Manavalan JS, Cremers S, Dempster DW, Zhou H, Dworakowski E, Kode A, Kousteni S and Rubin MR: Circulating osteogenic precursor cells in type 2 diabetes mellitus. J Clin Endocrinol Metabol. 97:3240–3250. 2012. View Article : Google Scholar
13	Fu R, Peng F, Liu H, Wang Y, Li L, Wang G, Song J and Shao Z: Clinical significance of osteoblast precursors and osteoclast precursors in earlier diagnosis and monitoring of myeloma bone disease. Ann Hematol. 95:1099–1106. 2016. View Article : Google Scholar : PubMed/NCBI
14	Flynn CM and Kaufman DS: Donor cell leukemia: Insight into cancer stem cells and the stem cell niche. Blood. 109:2688–2692. 2007.PubMed/NCBI
15	Dong M, Jiao G, Liu H, Wu W, Li S, Wang Q, Xu D, Li X, Liu H and Chen Y: Biological silicon stimulates collagen Type 1 and osteocalcin synthesis in human osteoblast-like cells through the BMP-2/Smad/RUNX2 signaling pathway. Biol Trace Elem Res. 173:306–315. 2016. View Article : Google Scholar : PubMed/NCBI
16	Grochowski CM, Loomes KM and Spinner NB: Jagged1 (JAG1): Structure, expression, and disease associations. Gene. 576:381–384. 2016. View Article : Google Scholar : PubMed/NCBI
17	Kode A, Manavalan JS, Mosialou I, Bhagat G, Rathinam CV, Luo N, Khiabanian H, Lee A, Murty VV, Friedman R, et al: Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts. Nature. 506:240–244. 2014. View Article : Google Scholar : PubMed/NCBI
18	Fu R, Gao S, Peng F, Li J, Liu H, Wang H, Xing L and Shao Z: Relationship between abnormal osteoblasts and cellular immunity in multiple myeloma. Cancer Cell Int. 14:622014. View Article : Google Scholar : PubMed/NCBI
19	Sakuishi K, Jayaraman P, Behar SM, Anderson AC and Kuchroo VK: Emerging Tim-3 functions in antimicrobial and tumor immunity. Trends Immunol. 32:345–349. 2011. View Article : Google Scholar : PubMed/NCBI
20	Tao JL, Li LJ, Fu R, Wang HQ, Jiang HJ, Yue LZ, Zhang W, Liu H, Ruan EB, Qu W, et al: Elevated TIM3+ hematopoietic stem cells in untreated myelodysplastic syndrome displayed aberrant differentiation, overproliferation and decreased apoptosis. Leuk Res. 38:714–721. 2014. View Article : Google Scholar : PubMed/NCBI